{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-010224","form_type":"8-K","ticker":"PMN","cik":"0001374339","company_name":"ProMIS Neurosciences Inc.","filed_at":"2024-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.822036+00:00","generated_at":"2026-05-31T15:56:28.177052+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ProMIS Neurosciences raises $30.3M in PIPE financing with warrants for up to $92.4M more","bullets":["Gross proceeds of $30.3M from sale of 9,757,669 common units at $2.15/unit and 4,371,027 pre-funded units at $2.14/unit.","Each unit includes one common share (or pre-funded warrant) and Tranche A, B, and C warrants with exercise prices of $2.02, $2.02, and $2.50, respectively.","Tranche A/B warrants subject to shareholder approval and expire upon 6-month or 12-month PMN310 data announcement; Tranche C expires July 31, 2029.","Proceeds to advance clinical development of PMN310, an antibody for Alzheimer's disease, plus working capital and general expenses.","All outstanding Series 2 Preferred Shares automatically convert into 1,166,667 common shares upon closing of this offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-010224","json":"https://secwatch.observer/filing/0001558370-24-010224.json","markdown":"https://secwatch.observer/filing/0001558370-24-010224.md","text":"https://secwatch.observer/filing/0001558370-24-010224.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1374339/000155837024010224/0001558370-24-010224-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1374339/000155837024010224/pmn-20240726x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:56:28.177052+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}